Document ID: chunk:federal_register_of_legislation:F2020L00489:reg:9
Version: federal_register_of_legislation:F2020L00489
Segment Type: reg
Provision Reference: reg 9
Character Range: 4111–5679

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting coeliac disease or death from coeliac disease with the circumstances of a person's relevant service:
(1)          being treated with interferon alpha within the six months before the clinical worsening of coeliac disease;
(2)          being treated with ribavirin within the six months before the clinical worsening of coeliac disease;
(3)          being treated with a proton pump inhibitor or a histamine-2 receptor antagonist, on more days than not, for at least the six months before the clinical worsening of coeliac disease;
            Note 1: Examples of proton pump inhibitors include esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole.
            Note 2: Examples of histamine-2 receptor antagonists include cimetidine, famotidine, nizatidine and ranitidine.
(4)          being treated with a non-selective, non-steroidal, anti-inflammatory agent, on more days than not, for at least the six months before the clinical worsening of coeliac disease;
            Note: Examples of non-selective, non-steroidal, anti-inflammatory agents include aspirin, diclofenac, ibuprofen, indomethacin, ketoprofen, ketorolac, mefenamic acid, naproxen, piroxicam and sulindac.
(5)          inability to maintain a gluten-free diet at the time of the clinical worsening of coeliac disease;
(6)          inability to obtain appropriate clinical management for coeliac disease.